Posted inGenetics
Low-Cost, Portable Biotech Tools Improve Access to Bioresearch and Diagnostics
Credit: Gorodenkoff/Getty Images A global research team headed by scientists at University of Toronto’s Leslie Dan Faculty of Pharmacy has…
Posted inGenetics
Circio and GenAssist Collaborate on Gene Therapy for Muscle Disease and In Vivo Cell Therapy
Credit: BSIP/Getty Images Oslo, Norway-based Circio and Suzhou, China-based GenAssist entered into a research collaboration to develop circVec-enhanced AAV vectors…
Posted inBiotechnology
Travere scales Everest with $1.1B deal for BTK inhibitor aimed at rare kidney diseases
Travere Therapeutics has set its sights on Everest Medicines' therapy for rare kidney diseases, paying $112.5 million upfront for a…
Posted inBiotechnology
Student-Athletes’ Struggle: Inside Their Sleep Challenges
In the high-stakes world of student athletics, where physical prowess and mental acuity are demanded in equal measure, sleep is…
Posted inBiotechnology
New heights for NewLimit as anti-aging biotech nabs $435M to rejuvenate old cells
Anti-aging startup NewLimit is back with a fresh fundraise of $435 million after landing on its first clinic-ready candidate years…
Posted inBiotechnology
Experimental Molecule “Reprograms” Brain’s Defenses to Combat Alzheimer’s Disease
In a groundbreaking advancement in Alzheimer’s disease research, scientists have unveiled a novel experimental molecule that “reprograms” the brain’s immune…
Posted inBiotechnology
Fulcrum scraps SCD program, considers options after FDA takes hard line on safety risks
Fulcrum Therapeutics has scrapped its sole clinical-stage program after the FDA took a hard line on the modality following the…
Posted inMedical Technology
Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo
Foundation Medicine tallied another nod from the FDA for one of its genomic profiling tests that searches for specific biomarkers…
Posted inBiotechnology
How Screens Are Reshaping Childhood: New Research Reveals the Developing Brain Integrates Experience Until Age 25, Impacting Mental Health Deeply
In an era where digital screens have become ever-present in the lives of children and adolescents, a groundbreaking neuroscientific framework…
Posted inBiotechnology
Praxis pauses one of its seizure programs after phase 2 fail
Praxis Precision Medicines’ epilepsy pipeline has suffered a setback after a next-gen NaV blocker failed to sufficiently reduce seizures in…